An updated meta-analysis investigates the relationship between tirzepatide and the incidence of atrial fibrillation in adults with overweight or obesity. The findings contribute to understanding the cardiovascular safety profile of tirzepatide in this patient population.
tirzepatide and the incidence of atrial fibrillation in adults with overweight or obesity an updated meta analysis of randomized controlled trials
Original title: “Tirzepatide and the Incidence of Atrial Fibrillation in Adults With Overweight or Obesity: An Updated Meta-Analysis of Randomized Controlled Trials.”